The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
HIF‐dependent induction of adenosine A2B receptor in hypoxia
Abstract
Adenosine has been widely associated with hypoxia of many origins, including those associated with inflammation and tumorogenesis. A number of recent studies have implicated metabolic control of adenosine generation at sites of tissue hypoxia. Here, we examine adenosine receptor control and amplification of signaling through transcriptional regulation of endothelial and epithelial adenosine receptors. Initial studies confirmed previous findings indicating selective induction of human adenosine A2B receptor (A2BR) by hypoxia. Analysis of the cloned human A2BR promoter identified a functional hypoxia‐responsive region, including a functional binding site for hypoxia‐inducible factor (HIF) within the A2BR promoter. Further studies examining HIF‐1α DNA binding and HIF‐1α gain and loss of function confirmed strong dependence of A2BR induction by HIF‐1α in vitro and in vivo mouse models. Additional studies in endothelia overexpressing full‐length A2BR revealed functional phenotypes of increased barrier function and enhanced angiogenesis. Taken together, these results demonstrate transcriptional coordination of A2BR by HIF‐1α and amplified adenosine signaling during hypoxia. These findings may provide an important link between hypoxia and metabolic conditions associated with inflammation and angiogenesis.—Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., Colgan, S. P. HIF‐dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242–2250 (2006)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Self-citationEpithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
Karhausen, J., Furuta, G. T., Tomaszewski, J. E., Johnson, R. S., Colgan, S. P., & Haase, V. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421086 · Cited by 655
Self-citationCorrection of sickle cell disease in transgenic mouse models by gene therapy
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., et al. (2001) · Science · doi:10.1126/science.1065806 · Cited by 579 · cited 1×
“The HIV-1 lentiviral vector used was based on a vector previously described in detail (41).”
Self-citationCrucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., & Colgan, S. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040915 · Cited by 543
Self-citationRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium
Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., & Colgan, S. P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030891 · Cited by 499
Self-citationFuruta, G. T., Turner, J. R., Taylor, C. T., Hershberg, R. M., Comerford, K., Narravula, S., Podolsky, D. K., & Colgan, S. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1027 · Cited by 449
Self-citationHIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
Eltzschig, H. K., Abdulla, P., Hoffman, E., Hamilton, K. E., Daniels, D., Schönfeld, C., Löffler, M., Reyes, G., Duszenko, M., Karhausen, J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050177 · Cited by 351
Self-citationPinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278
Feoktistov, I., Goldstein, A. E., Ryzhov, S., Zeng, D., Belardinelli, L., Voyno-Yasenetskaya, T., & Biaggioni, I. (2002) · Circulation Research · doi:10.1161/01.res.0000012203.21416.14 · Cited by 270
Hypoxia-Induced Inhibition of Adenosine Kinase Potentiates Cardiac Adenosine Release
Decking, U. K. M., Schlieper, G., Kroll, K., & Schrader, J. (1997) · Circulation Research · doi:10.1161/01.res.81.2.154 · Cited by 265
Kimura, H., Weisz, A., Ogura, T., Hitomi, Y., Kurashima, Y., Hashimoto, K., D'Acquisto, F., Makuuchi, M., & Esumi, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008398200 · Cited by 259
Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P., & Shelley, C. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401339101 · Cited by 242
Self-citationOverexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression
Li, S., Huang, S., & Peng, S.-B. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.5.1329 · Cited by 233
Montesinos, M. C., Desai, A., Chen, J.-F., Yee, H., Schwarzschild, M. A., Fink, J. S., & Cronstein, B. N. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61151-0 · Cited by 231
Lennon, P. F., Taylor, C. T., Stahl, G. L., & Colgan, S. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1433 · Cited by 229
Self-citationStrohmeier, G. R., Reppert, S. M., Lencer, W. I., & Madara, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2387 · Cited by 224
A glance at adenosine receptors: novel target for antitumor therapy
Merighi, S., Mirandola, P., Varani, K., Gessi, S., Leung, E., Baraldi, P. G., Tabrizi, M. A., & Borea, P. A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00084-6 · Cited by 214
Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gαs-linked) Receptors
Montesinos, M. C., Gadangi, P., Longaker, M., Sung, J., Levine, J., Nilsen, D., Reibman, J., Li, M., Jiang, C.-K., Hirschhorn, R., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1615 · Cited by 213
Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease
Giatromanolaki, A., Sivridis, E., Maltezos, E., Papazoglou, D., Simopoulos, C., Gatter, K. C., Harris, A. L., & Koukourakis, M. I. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.209 · Cited by 208
Odashima, M., Bamias, G., Rivera-Nieves, J., Linden, J., Nast, C. C., Moskaluk, C. A., Marini, M., Sugawara, K., Kozaiwa, K., Otaka, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.032 · Cited by 205
Pugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
Leibovich, S. J., Chen, J.-F., Pinhal-Enfield, G., Belem, P. C., Elson, G., Rosania, A., Ramanathan, M., Montesinos, C., Jacobson, M., Schwarzschild, M. A., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61170-4 · Cited by 196
Sitaraman, S. V., Merlin, D., Wang, L., Wong, M., Gewirtz, A. T., Si-Tahar, M., & Madara, J. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11783 · Cited by 182
Maxwell, P. H. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.001 · Cited by 167
Inflammatory Hypoxia: Role of Hypoxia-Inducible Factor
Karhausen, J., Haase, V. H., & Colgan, S. P. (2005) · Cell Cycle · doi:10.4161/cc.4.2.1407 · Cited by 164
Self-citationFeoktistov, I., Ryzhov, S., Zhong, H., Goldstein, A. E., Matafonov, A., Zeng, D., & Biaggioni, I. (2004) · Hypertension · doi:10.1161/01.hyp.0000144800.21037.a5 · Cited by 163
Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts
Zhong, H., Belardinelli, L., Maa, T., & Zeng, D. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0103oc · Cited by 146
A Dominant-Negative p65 PAK Peptide Inhibits Angiogenesis
Kiosses, W. B., Hood, J. D., Yang, S., Gerritsen, M. E., Cheresh, D. A., Alderson, N. B., & Schwartz, M. A. (2002) · Circulation Research · doi:10.1161/01.res.0000014227.76102.5d · Cited by 130
Montesinos, M. C., Shaw, J. P., Yee, H. T., Shamamian, P. E., & Cronstein, B. N. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63749-2 · Cited by 128
A3 adenosine receptor as a target for cancer therapy
Fishman, P., Bar‐Yehuda, S., Madi, L., & Cohn, I. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200206000-00001 · Cited by 127
Desai, A., Victor-Vega, C., Gadangi, S., Montesinos, M. C., Chu, C. C., & Cronstein, B. N. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007807 · Cited by 115
Holgate, S. T. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706272 · Cited by 93
[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors
Ji, X.-D., Kim, Y., Ahern, D. G., Linden, J. M., & Jacobson, K. A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00531-7 · Cited by 92
DBTSS: DataBase of Human Transcription Start Sites, progress report 2006
Yamashita, R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj129 · Cited by 90
HIF‐dependent induction of apical CD55 coordinates epithelial clearance of neutrophils
Louis, N. A., Hamilton, K. E., Kong, T., & Colgan, S. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3251com · Cited by 72
Self-citationDynamic purine signaling and metabolism during neutrophil–endothelial interactions
Weissmüller, T., Eltzschig, H. K., & Colgan, S. P. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-6323-9 · Cited by 30
Self-citationTang, C., Hoerning, A., Büscher, R., O’Connor, D. T., Ratjen, F. A., Grasemann, H., & Insel, P. A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200505000-00007 · Cited by 8
Cited by
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
Self-citationAdenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Self-citationTargeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Purinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 706
Self-citation
Metadata
- Authors
- Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., & Colgan, S. P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-11
- Volume
- 20
- Issue
- 13
- Pages
- 2242-2250
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2082083390
- Cited by
- 335
- References
- 42
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.